Clinical Trial Update: A Safety Study Using Pentamidine in Patients With Pancreatic Cancer Undergoing Standard Therapy [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 safety study evaluating pentamidine in patients with pancreatic cancer undergoing standard therapy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Pentamidine (pentamidine)

Snippet

Sponsor: Oncozyme Pharma Inc. | Conditions: Pancreatic Cancer | Phase 1, Phase 2 | Status: COMPLETED